Table 2 Effect of concentration of aspirin, quercetin and PG9 capped and quercetin functionalized AuNPs on the % inhibition of hemolysis

200

− 24.70 ± 5.03

7.50 ± 7.64

48.60 ± 8.50

400

− 17.02 ± 2.98

27.22 ± 6.22

56.33 ± 15.09

600

− 4.68 ± 2.49

65.05 ± 6.36

59.08 ± 1.65

800

− 27.60 ± 6.66

89.51 ± 5.49

52.86 ± 3.97

1000

− 14.81 ± 3.4

93.27 ± 10.89

69.90 ± 3.77

1200

− 13.58 ± 0.91

95.36 ± 6.53

73.35 ± 8.51

1400

− 9.26 ± 0.74

97.62 ± 8.19

74.51 ± 21.16

1600

6.18 ± 1.51

99.51 ± 6.55

87.46 ± 6.83

1800

3.51 ± 1.3

93.97 ± 8.41

88.52 ± 8.67

2000

3.48 ± 1.61

96.85 ± 6.67

91.26 ± 6.25

IC50

− 14.195 ± 2.15

94.315 ± 8.71

71.62 ± 6.14